Assessing the Risk of Institutionalization to Convalescent Hospital in Alzheimer’s Disease Compared to Mild Cognitive Impairment Using Inverse Propensity Weighted Cox Model

Author(s)

Kim M1, Suh HS2
1College of Pharmacy, Kyung Hee University, Institute of Regulatory Innovation through Science, Kyung Hee University, College of Pharmacy, Pusan National University, Seoul, South Korea, 2College of Pharmacy, Kyung Hee University, Department of Regulatory Science, Graduate School, Kyung Hee University, Institute of Regulatory Innovation through Science, Kyung Hee University, Seoul, Korea, Republic of (South)

OBJECTIVES: To estimate the incidence rate and the risk of institutionalization in convalescent hospitals among community-dwelling patients with mild cognitive impairment (MCI) or Alzheimer’s disease (AD).

METHODS: A retrospective cohort study was conducted using the Health Insurance Review and Assessment database covering the entire Korean population from JUL 01/2019 to NOV 30/2022. The study focused on patients diagnosed with MCI or AD between JAN 01/2020 and JUN 01/2022 with the index date defined as the first diagnosis date. Institutionalization was defined as a continuous enrollment in a convalescent hospital for over six months. We excluded the patients already residing in a convalescent hospital six months before the index date. The primary outcome was the incidence of institutionalization in convalescent hospitals for MCI or AD patients. The incidence rate per 1000 person-years was calculated, and the risk of institutionalization for AD patients compared to MCI was estimated using hazard ratios (HR) with 95% confidence intervals from a Cox proportional hazards model. To control for confounders including age, sex, type of insurance, Charlson comorbidity index, and infectious diseases, inverse propensity weighting was employed.

RESULTS: The study included 40.8% (n=422,934) patients with MCI and 59.2% (n=613,920) patients with AD. The mean age differed between the two groups (71.7±9.4 years for MCI vs. 80.5±7.8 years for AD). The institutionalization rate per 1000 person-years was different between patients with MCI (0.65[0.59-0.71]) and AD (13.8[13.6-14.0]). The risk of institutionalization was significantly higher in patients with AD compared to MCI (unadjusted HR, 16.6[15.1-18.2]; adjusted HR, 9.2[8.8-9.5]).

CONCLUSIONS: This study provides real-world evidence demonstrating a higher incidence rate and increased risk of institutionalization in convalescent hospitals for patients with AD compared to those with MCI using large population-based data. Inverse propensity weighting was employed to adjust for confounding factors commonly present in observational studies, resulting in more robust and reliable findings.

Conference/Value in Health Info

2024-11, ISPOR Europe 2024, Barcelona, Spain

Value in Health, Volume 27, Issue 12, S2 (December 2024)

Code

MSR30

Topic

Clinical Outcomes, Epidemiology & Public Health, Methodological & Statistical Research

Topic Subcategory

Comparative Effectiveness or Efficacy, Confounding, Selection Bias Correction, Causal Inference

Disease

Geriatrics, Mental Health (including addition), Neurological Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×